You are here:

  1. Home
  2. NICE Guidance
  3. Conditions and diseases
  4. Infections
  5. Hepatitis

Bulevirtide for treating chronic hepatitis D

  • Technology appraisal guidance
  • Reference number: TA896
  • Published:  07 June 2023
  • Guidance
  • Tools and resources
  • Information for the public
  • Evidence
  • History

On this page

  1. Expected publication
  2. Final draft guidance
  3. Draft guidance: 1
  4. Invitation to participate

History

A list of downloadable documents created during development.

Expected publication

  • Register of interests (PDF 265 KB)

    Published:
    30 November 2023

Final draft guidance

  • Final draft guidance

  • Final appraisal document (PDF 275 KB)

    Published:
    15 May 2023
  • Public committee slides (PowerPoint 619 KB)

    Published:
    15 May 2023
  • Committee papers (PDF 3.15 MB)

    Published:
    15 May 2023

Draft guidance: 1

  • Draft guidance: 1

  • Appraisal consultation document (online commenting)

  • Committee papers (PDF 3.77 MB)

    Published:
    04 November 2022
  • Public committee slides (PowerPoint 688 KB)

    Published:
    04 November 2022
  • Appraisal consultation document (PDF version) (PDF 283 KB)

    Published:
    04 November 2022

Invitation to participate

  • Final scope (PDF 179 KB)

    Published:
    14 February 2022
  • Final stakeholder list (PDF 190 KB)

    Published:
    14 February 2022
  • NICE's response to comments on the draft scope and provisional stakeholder list (PDF 507 KB)

    Published:
    14 February 2022
  • Equality impact assessment (Scoping) (PDF 126 KB)

    Published:
    14 February 2022
Back to top